Bempegaldesleukin |
BMS-986321; ONO-7911; NKTR-214 |
Phase 3 Clinical |
Nektar Therapeutics |
Coronavirus Disease 2019 (COVID-19); Melanoma; Glioma; Lymphoma; Sarcoma, Ewing; Brain Neoplasms; Neuroblastoma; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms; Ependymoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Rhabdomyosarcoma; Head and Neck Neoplasms; Leukemia; Medulloblastoma; Solid tumours |
Details
|
Nanrilkefusp alfa |
SO-C101; RLI-15; CYP-0150; SOT-101 |
Phase 2 Clinical |
|
Microsatellite instability-high cancer; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Squamous Cell; Colorectal Neoplasms; Thymus Neoplasms; Urinary Bladder Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Thyroid Diseases; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Anus Neoplasms; Ovarian Neoplasms; Biliary Tract Neoplasms |
Details
|
GI-101 |
SIM-323; SIM323; GI-101 |
Phase 2 Clinical |
GI Innovation Inc |
Solid tumours; Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Vaginal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Urinary Bladder Neoplasms; Sarcoma; Vulvar Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis |
Details
|
THOR-707 |
THOR-707; SAR-444245 |
Phase 2 Clinical |
Synthorx Inc |
Oropharyngeal Neoplasms; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Esophageal adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Colorectal Neoplasms; Intestinal Neoplasms; Mesothelioma; Skin Neoplasms; Lymphoma, Large B-Cell, Diffuse; Hodgkin Disease; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Head and Neck Neoplasms |
Details
|
IPH-6501 |
IPH-6501; IPH-65 |
Phase 2 Clinical |
Innate Pharma SA |
Neoplasms; Lymphoma, Non-Hodgkin |
Details
|
IAP-0971 |
IAP-0971 |
Phase 2 Clinical |
SunHo (China) BioPharmaceutical Co Ltd |
Solid tumours; Neoplasms; Urinary Bladder Neoplasms |
Details
|
TransCon IL-2 β/γ |
|
Phase 2 Clinical |
Ascendis Pharma A/S |
Head and Neck Neoplasms; Solid tumours; Ovarian Neoplasms; Neoplasm Metastasis |
Details
|
MDNA-11 |
MDNA-11; MDNA11 |
Phase 2 Clinical |
Medicenna Therapeutics Corp |
Triple Negative Breast Neoplasms; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Squamous Cell; Peritoneal Neoplasms; Mesothelioma; Urinary Bladder Neoplasms; Skin Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Stomach Neoplasms; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Esophageal Neoplasms; Gastrointestinal Diseases; Carcinoma, Basal Cell; Ovarian Neoplasms; Skin Melanoma |
Details
|
Simlukafusp alfa |
FAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FP |
Phase 1 Clinical |
F. Hoffmann-La Roche Ltd |
Head and Neck Neoplasms; Solid tumours; Carcinoma, Renal Cell; Esophageal Neoplasms; Breast Neoplasms; Uterine Cervical Neoplasms; Melanoma |
Details
|
BJ-001(Boji Biomedical Technology) |
BJ-001 |
Phase 1 Clinical |
Boji Biomedical Technology (Hangzhou) Co Ltd |
Solid tumours; Communicable Diseases; Neoplasm Metastasis |
Details
|
STK-009 |
STK-009 |
Phase 1 Clinical |
Synthekine Inc |
Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lupus Nephritis; Lupus Erythematosus, Systemic; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
FB-102 |
FB-102; FB102 |
Phase 1 Clinical |
Forte Biosciences Inc |
Alopecia Areata; Graft vs Host Disease; Vitiligo; Malabsorption Syndromes |
Details
|
NL-201 (Neoleukin Therapeutics) |
NL-201 |
Phase 1 Clinical |
Neoleukin Therapeutics Inc |
Solid tumours |
Details
|
Recombinant human interleukin 15(Beijing Kawin) |
|
Phase 1 Clinical |
Beijing Kawin Technology Share-Holding Co Ltd |
Solid tumours |
Details
|
Bempegaldesleukin |
BMS-986321; ONO-7911; NKTR-214 |
Phase 3 Clinical |
Nektar Therapeutics |
Coronavirus Disease 2019 (COVID-19); Melanoma; Glioma; Lymphoma; Sarcoma, Ewing; Brain Neoplasms; Neuroblastoma; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms; Ependymoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Rhabdomyosarcoma; Head and Neck Neoplasms; Leukemia; Medulloblastoma; Solid tumours |
Details
|
Nanrilkefusp alfa |
SO-C101; RLI-15; CYP-0150; SOT-101 |
Phase 2 Clinical |
|
Microsatellite instability-high cancer; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Squamous Cell; Colorectal Neoplasms; Thymus Neoplasms; Urinary Bladder Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Thyroid Diseases; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Anus Neoplasms; Ovarian Neoplasms; Biliary Tract Neoplasms |
Details
|
GI-101 |
SIM-323; SIM323; GI-101 |
Phase 2 Clinical |
GI Innovation Inc |
Solid tumours; Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Vaginal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Urinary Bladder Neoplasms; Sarcoma; Vulvar Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis |
Details
|
THOR-707 |
THOR-707; SAR-444245 |
Phase 2 Clinical |
Synthorx Inc |
Oropharyngeal Neoplasms; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Esophageal adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Colorectal Neoplasms; Intestinal Neoplasms; Mesothelioma; Skin Neoplasms; Lymphoma, Large B-Cell, Diffuse; Hodgkin Disease; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Head and Neck Neoplasms |
Details
|
IPH-6501 |
IPH-6501; IPH-65 |
Phase 2 Clinical |
Innate Pharma SA |
Neoplasms; Lymphoma, Non-Hodgkin |
Details
|
IAP-0971 |
IAP-0971 |
Phase 2 Clinical |
SunHo (China) BioPharmaceutical Co Ltd |
Solid tumours; Neoplasms; Urinary Bladder Neoplasms |
Details
|
TransCon IL-2 β/γ |
|
Phase 2 Clinical |
Ascendis Pharma A/S |
Head and Neck Neoplasms; Solid tumours; Ovarian Neoplasms; Neoplasm Metastasis |
Details
|
MDNA-11 |
MDNA-11; MDNA11 |
Phase 2 Clinical |
Medicenna Therapeutics Corp |
Triple Negative Breast Neoplasms; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Squamous Cell; Peritoneal Neoplasms; Mesothelioma; Urinary Bladder Neoplasms; Skin Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Stomach Neoplasms; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Esophageal Neoplasms; Gastrointestinal Diseases; Carcinoma, Basal Cell; Ovarian Neoplasms; Skin Melanoma |
Details
|
Simlukafusp alfa |
FAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FP |
Phase 1 Clinical |
F. Hoffmann-La Roche Ltd |
Head and Neck Neoplasms; Solid tumours; Carcinoma, Renal Cell; Esophageal Neoplasms; Breast Neoplasms; Uterine Cervical Neoplasms; Melanoma |
Details
|
BJ-001(Boji Biomedical Technology) |
BJ-001 |
Phase 1 Clinical |
Boji Biomedical Technology (Hangzhou) Co Ltd |
Solid tumours; Communicable Diseases; Neoplasm Metastasis |
Details
|
STK-009 |
STK-009 |
Phase 1 Clinical |
Synthekine Inc |
Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lupus Nephritis; Lupus Erythematosus, Systemic; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
FB-102 |
FB-102; FB102 |
Phase 1 Clinical |
Forte Biosciences Inc |
Alopecia Areata; Graft vs Host Disease; Vitiligo; Malabsorption Syndromes |
Details
|
NL-201 (Neoleukin Therapeutics) |
NL-201 |
Phase 1 Clinical |
Neoleukin Therapeutics Inc |
Solid tumours |
Details
|
Recombinant human interleukin 15(Beijing Kawin) |
|
Phase 1 Clinical |
Beijing Kawin Technology Share-Holding Co Ltd |
Solid tumours |
Details
|